Influx Health.
INFLUX

Influx Health.

Pharmaceuticals
Share price
₹285
Market cap
₹631 Cr
1Y return
▲ 27%

A healthcare-focused contract manufacturing company incorporated in September 2020, Influx Healthtech specializes in producing pharmaceutical products for partner companies across India. The firm operates in the contract manufacturing sector, providing comprehensive end-to-end production capabilities and quality assurance services to pharmaceutical clients. Its business model centers on offering reliable, scalable manufacturing services to established pharmaceutical brands seeking outsourced production capacity and operational efficiency.

Investors holding Influx Health.

Recent moves 3

Finavenue Growth FundExited
Finavenue Growth Fund has slipped off the latest Influx Health shareholder list, indicating either a complete exit or a trim below the 1 percent reporting threshold from its previously disclosed 1.35 percent stake.
17 Oct 2026
Read more
Solidarity AdvisorsNew position
Solidarity Advisors added over 0.76% of Influx Health and now holds 1.76%, or 4,06,800 shares.
17 Oct 2026
Read more
Aarth AIF Growth FundDecreased
Aarth AIF Growth Fund sold 82,200 shares of Influx Healthtech, reducing its stake from 1.40% to 1.04%.
17 Oct 2026
Read more

Track the whales in Influx Health.

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1